Erratum: The affinity of D 2 -like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration (Journal of Pharmacology and Experimental Therapeutics (2011) 338 (724-728) DOI: 10.1124/jpet.111.183244);The affinity of D 2 -like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 2, 2011, Pages 724-728

  Norman, Andrew B ^a   Tabet, Michael R ^a   Norman, Mantana K ^a   Fey, Brittney K ^a   Tsibulsky, Vladimir L ^a   Millard, Ronald W ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; EMONAPRIDE; ETICLOPRIDE; HALOPERIDOL; MOLINDONE; OLANZAPINE; SPIPERONE; THIORIDAZINE; TRIFLUPROMAZINE; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; COCAINE DEPENDENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SELF ADMINISTRATION; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; SATIETY; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PROTEIN BINDING; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; COCAINE; DOPAMINE ANTAGONISTS; MALE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SELF ADMINISTRATION; TIME FACTORS;

EID: 79960519503     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.183244err     Document Type: Erratum

References (25)

1. Colquhoun D (2007) Why the Schild method is better than Schild realised. Trends Pharmacol Sci 28:608-614.
2. Creese I, Burt DR, and Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483.
3. Ettenberg A, Pettit HO, Bloom FE, and Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204-209. (Pubitemid 13250843)
4. 11 C-raclopride. Psychopharmacology 92:278-284.
5. Gifford AN, Gatley SJ, and Volkow ND (1998) Evaluation of the importance of rebinding to receptors in slowing the approach to equilibrium of high-affinity PET and SPECT radiotracers. Synapse 28:167-175. (Pubitemid 28027754)
6. Hamblin MW, Leff SE, and Creese I (1984) Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. Biochem Pharmacol 33:877-887. (Pubitemid 14171664)
7. Hietala J, Seppäla T, Lappalainen J, and Syvälahti E (1992) Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood. Psychopharmacology 106:455-458.
8. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
9. Kilts CD, Dew KL, Ely TD, and Mailman RB (1985) Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3-benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection. J Chromatogr 342:452-457.
10. 2 receptors: evidence for identical binding sites. Eur J Pharmacol 303:123-128.
11. Nicolaysen LC, Pan HT, and Justice JB Jr (1988) Extracellular cocaine and dopamine concentrations are linearly related in rat striatum. Brain Res 456:317-323.
12. Norman AB, Norman MK, Tabet MR, Tsibulsky VL, and Pesce AJ (2011a) Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration. Synapse 65:404-411.
13. Norman AB, Tabet MR, Norman MK, and Tsibulsky VL (2011b) Using the selfadministration of apomorphine and cocaine to measure the pharmacodynamic potencies and pharmacokinetics of competitive dopamine receptor antagonists. J Neurosci Methods 194:252-258.
14. Norman AB and Tsibulsky VL (2006) The compulsion zone: a pharmacological theory of acquired cocaine self-administration. Brain Res 1116:143-152. (Pubitemid 44485005)
15. Roberts DC and Vickers G (1984) Atypical neuroleptics increase self-administration of cocaine: an evaluation of a behavioural screen for antipsychotic activity. Psychopharmacology 82:135-139. (Pubitemid 14222301)
16. Scherrer RA and Howard SM (1977) Use of distribution coefficients in quantitative structure-activity relationships. J Med Chem 20:53-58. (Pubitemid 8020532)
17. Schild HO (1947) pA, a new scale for the measurement of drug antagonism. Br J Pharmacol Chemother 2:189-206.
18. Schild HO (1957) Drug antagonism and pAx. Pharmacol Rev 9:242-246.
19. Seelig A (1998) A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 251:252-261.
20. Seeman P (1993) Receptor Tables, Vol. 2: Drug Dissociation Constants for Neuroreceptors and Transporters, SZ Research, Toronto, ON, Canada.
21. Seeman P (2010) Dopamine D2 receptors as treatment targets in schizophrenia. Clin Schizophr Relat Psychoses 1:56-73.
22. Seeman P, Lee T, Chau-Wong M, and Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719.
23. Tsibulsky VL and Norman AB (1999) Satiety threshold: a quantitative model of maintained cocaine self-administration. Brain Res 839:85-93. (Pubitemid 29389796)
24. Tsibulsky VL and Norman AB (2005) Real time computation of in vivo drug levels during drug self-administration experiments. Brain Res Brain Res Protoc 15:38-45. (Pubitemid 40616870)
25. Wang YH, Li Y, Yang SL, and Yang L (2005) Classification of substrates and inhibitors of P-glycoprotein using unsupervised machine learning approach. J Chem Inf Model 45:750-757. (Pubitemid 40795178)